Stavros Petrou

2001–2025 年に発表

146
論文数
22,395
被引用数
67
h 指数
135
i10 指数

被引用数

Stavros Petrou の年別被引用数1989 年: 被引用 1 件1993 年: 被引用 1 件1999 年: 被引用 1 件2001 年: 被引用 1 件2002 年: 被引用 3 件2003 年: 被引用 10 件2004 年: 被引用 9 件2005 年: 被引用 15 件2006 年: 被引用 26 件2007 年: 被引用 34 件2008 年: 被引用 24 件2009 年: 被引用 31 件2010 年: 被引用 41 件2011 年: 被引用 28 件2012 年: 被引用 46 件2013 年: 被引用 54 件2014 年: 被引用 59 件2015 年: 被引用 91 件2016 年: 被引用 88 件2017 年: 被引用 83 件2018 年: 被引用 107 件2019 年: 被引用 692 件2020 年: 被引用 771 件2021 年: 被引用 740 件2022 年: 被引用 582 件2023 年: 被引用 502 件2024 年: 被引用 905 件2025 年: 被引用 272 件2026 年: 被引用 11 件1990〜1992 年は被引用が無いため表示していません1994〜1998 年は被引用が無いため表示していません2000 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,732 件、この内訳の 18%イギリス: 引用元論文 1,344 件、この内訳の 14%カナダ: 引用元論文 573 件、この内訳の 6%オーストラリア: 引用元論文 563 件、この内訳の 5.9%中国: 引用元論文 495 件、この内訳の 5.2%オランダ: 引用元論文 409 件、この内訳の 4.3%ドイツ: 引用元論文 359 件、この内訳の 3.7%イタリア: 引用元論文 331 件、この内訳の 3.4%フランス: 引用元論文 281 件、この内訳の 2.9%スイス: 引用元論文 236 件、この内訳の 2.5%スペイン: 引用元論文 230 件、この内訳の 2.4%スウェーデン: 引用元論文 194 件、この内訳の 2%
0%18%その他 29.7%

分野

  • Medicine73.5%
  • Economics, Econometrics and Finance5.4%
  • Health Professions3.4%
  • Psychology3.1%
  • Immunology and Microbiology2.8%
  • Neuroscience2.6%
  • その他9.2%

トピック

  • Health Systems, Economic Evaluations, Quality of Life2.7%
  • Venous Thromboembolism Diagnosis and Management2.5%
  • Infant Development and Preterm Care2.3%
  • Preterm Birth and Chorioamnionitis2%
  • Neonatal Respiratory Health Research2%
  • Cardiac Arrest and Resuscitation1.5%
  • その他87%

共著者

全論文

検索で開く
  1. Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2021 被引用: 1,464

  2. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force

    著者: , , , , , , , , , , , , , , - Value in Health 2022 被引用: 830

  3. Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michelle A. Detry, Christina Saunders, Mark Fitzgerald, Nicholas Berry, Lazaro Mwandigha, Ushma Galal, Sam Mort, Bhautesh Jani, Nigel Hart, Haroon Ahmed, Daniel Butler, Micheal McKenna, Jem Chalk, Layla Lavallee, Elizabeth Hadley, Lucy Cureton, Magdalena Benysek, Monique Andersson, Maria Coates, Sarah Barrett, Clare Bateman, Jennifer Davies, Ivy Raymundo-Wood, Andrew Ustianowski, Andrew Carson‐Stevens, Ly‐Mee Yu, Paul Little, Akosua Adom Agyeman, Tanveer Ahmed, Damien Allcock, Adrian Beltran-Martinez, Oluseye E Benedict, Nigel C. Bird, Laura K. Brennan, Julianne R. Brown, Gerard P. Burns, Mike Butler, Zelda Cheng, Ruth Danson, Nigel de Kare-Silver, Devesh Dhasmana, Jon M Dickson, Serge Engamba, Stacey Fisher, Robin Fox, Eve Frost, Richard A. Gaunt, Sarit K. Ghosh, Ishtiaq A Gilkar, Anna L. Goodman, Steve Granier, Aleksandra Howell, Iqbal Hussain, Simon M. Hutchinson, Marie Imlach, Greg Irving, Nicholas Jacobsen, James Kennard, Umar Khan, Kyle Knox, Christopher Krasucki, Tom Law, Rem Lee, Nicola Lester, David Lewis, J.A. Lunn, Claire I. Mackintosh, Mehul Mathukia, Patrick S. Moore, Seb Morton ほか 35 名 - The Lancet 2022 被引用: 406

  4. Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)

    著者: , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2018 被引用: 1,326

  5. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force

    著者: , , , , , , , , , - Value in Health 2013 被引用: 2,058

  6. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations

    著者: , , , , , , , , , , , , , , - Applied Health Economics and Health Policy 2022 被引用: 997

  7. A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest

    著者: , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2018 被引用: 790

  8. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement

    著者: , , , , , , , , , , - BMJ 2013 被引用: 1,765

  9. Dementia And Physical Activity (DAPA) trial of moderate to high intensity exercise training for people with dementia: randomised controlled trial

    著者: , , , , , , , , , , - BMJ 2018 被引用: 414

  10. Development and internal-external validation of statistical and machine learning models for breast cancer prognostication: cohort study

    著者: , , , , , , - BMJ 2023 被引用: 92

  11. Hip arthroscopy versus best conservative care for the treatment of femoroacetabular impingement syndrome (UK FASHIoN): a multicentre randomised controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , M.R. Norton, Tim Board, Aslam Mohammed, Asim Rajpura, Michael Cronin, Wael Dandachli, Johan Witt, S.J. Eastaugh-Waring, Max Fehily, Darren Fern, Richard Field, Giles H. Stafford, Aresh Hashemi-Nejad, Tahir Khan, Venu Kavathapu, Nigel Kiely, John Paul Whitaker, Paul Latimer, Sanjeev Madan, Ajay Malviya, Sanjeev Patil, Manoj Ramachandran, Seb Sturridge, Phillip Thomas, Craig A. White, Matthew Wilson, Mark R. Williams, Emma Jones, Simon Baker, Joanna Stanton, Charlotte Nicholls, Alison Smeatham, Lucie Gosling, Katte MacFarlane, Fraser Pressdee, Gareth Dickinson, Karen Boulton, Jill Goss, Rina Venter, Jamila Kassam, Rachel Simmons, Kathryn Poll, Thomas Bergmann, Margaret Pilkington, Jo Armstrong, Daniel R. Wright, Philippa Dolphin, Kelly Bainbridge, Miles Callum, Anthony Lewis, Evonne Smith, Veronica Cornes, Joanna Benfield, Katie Monnington, Emma Stewart, Steven Borrill, Megan Pinches, Sam Dawson, Noël Harding, Matthew Willis, D WINSLOW MOORE, Andrew MacCauley, David T. Cooke, Rebecca Fleck, Julliet Ball, Peter Morrison, Michael Kennedy, Sylvia Turner, Charlotte Bryant, Kirsten Harris ほか 28 名 - The Lancet 2018 被引用: 550

  12. Indirect effects of childhood pneumococcal conjugate vaccination on invasive pneumococcal disease: a systematic review and meta-analysis

    著者: , , , , , , , - The Lancet Global Health 2016 被引用: 226

  13. Discrete Choice Experiments in Health Economics: A Review of the Literature

    著者: , , , , - PharmacoEconomics 2014 被引用: 876

  14. Consolidated Health Economic Evaluation Reporting Standards for Interventions That Use Artificial Intelligence (CHEERS-AI)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David Vanness, Rossella Di Bidino, Susan Faulding, Federico Felizzi, Madeleine Haig, James Hawkins, Mikaël Hiligsmann, Annette Willemoes Holst-Kristensen, Julian Isla, Erik Koffijberg, Alexander Kostyuk, Noemi Krief, Dawn Lee, Karen Lee, Douglas Lundin, Katarzyna Markiewicz-Barreaux, Josephine Mauskopf, Karel Moons, Bertalan Németh, Guenka Petrova, Raoh-Fang (Jasmine) Pwu, Juan Carlos Rejon-Parrilla, Gabriel Rogers, Chris Sampson, Astrid Aaen Springborg, Lotte Steuten, Eric Sutherland, Jaakko Suutala, Daniel Theisen, Alexander Thompson, Lisette van Gemert-Pijnen, Thomas Walker, Ed Wilson - Value in Health 2024 被引用: 57

  15. Clinical and cost-effectiveness of nurse-delivered sleep restriction therapy for insomnia in primary care (HABIT): a pragmatic, superiority, open-label, randomised controlled trial

    著者: , , , , , , , , , , , , , , , , , , - The Lancet 2023 被引用: 82

  16. Systematic Review of Conceptual, Age, Measurement and Valuation Considerations for Generic Multidimensional Childhood Patient-Reported Outcome Measures

    著者: , , , , , , , , , , , , , , , , , , , , - PharmacoEconomics 2022 被引用: 77

  17. WAO consensus on DEfinition of Food Allergy SEverity (DEFASE)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matthew Greenhawt, María Antonieta Guzmán, Elham Hossny, Paula Kauppi, Carla Jones, Francesco Lucidi, Olga Patricia Monge-Ortega, Daniel Munblit, Antonella Muraro, Giovanni Battista Pajno, Márcia Helena Miranda Cardoso Podestá, Pablo Rodríguez del Río, Maria Said, Alexandra F. Santos, Marcus Shaker, Hania Szajewska, Carina Venter, Cristopher Warren, Tonya Winders, Motohiro Ebisawa, Alessandro Fiocchi - World Allergy Organization Journal 2023 被引用: 53

  18. The current status of risk-stratified breast screening

    著者: , , , , , , - British Journal of Cancer 2021 被引用: 127

  19. CONSOLIDATED HEALTH ECONOMIC EVALUATION REPORTING STANDARDS (CHEERS) STATEMENT

    著者: , , , , , , , , , - BJOG An International Journal of Obstetrics & Gynaecology 2013 被引用: 681

  20. Exercise versus usual care after non-reconstructive breast cancer surgery (UK PROSPER): multicentre randomised controlled trial and economic evaluation

    著者: , , , , , , , , , , , , - BMJ 2021 被引用: 72

  21. Neurodevelopmental outcomes following late and moderate prematurity: a population-based cohort study

    著者: , , , , , , , , , , - Archives of Disease in Childhood Fetal & Neonatal 2015 被引用: 274

  22. Economic consequences of preterm birth: a systematic review of the recent literature (2009–2017)

    著者: , , - Archives of Disease in Childhood 2018 被引用: 148

  23. Impact of Long COVID on productivity and informal caregiving

    著者: , , , , , , , , - The European Journal of Health Economics 2023 被引用: 55

  24. Effect of national guidance on survival for babies born at 22 weeks’ gestation in England and Wales: population based cohort study

    著者: , , , , , , , - BMJ Medicine 2023 被引用: 42